Physician profile
Tania Lamba
NPI 1497911598
$608.27
in general payments reported to CMS, 2019-2025
13 companies · $18.61 in 2025
The $18.61 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.85 · 2020: $112 · 2021: $31.96 · 2022: $203 · 2023: $159 · 2024: $28.43 · 2025: $18.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $148.00 | 2019-2022 | |
| Glaxosmithkline, LLC. | $126.83 | 2022 | |
| Abbvie INC. | $82.54 | 2023 | |
| Iridex Corporation | $45.10 | 2020 | |
| Sight Sciences, INC. | $30.89 | 2021-2023 | Omni Surgical System |
| Carl Zeiss Meditec USA, INC. | $28.43 | 2024 | Quatera 700 |
| Alimera Sciences, INC. | $26.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.80 | 2019 | |
| Thea Pharma INC. | $22.86 | 2023 | Iyuzeh |
| Alcon Vision LLC | $20.42 | 2023 | Clareon |
| Bausch & Lomb Americas INC. | $19.96 | 2023 | Vyzulta |
| Astellas Pharma US INC | $18.61 | 2025 | Izervay |
| Aerie Pharmaceuticals, INC. | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Lamba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.